The Company is developing a range of nutritional products to regulate energy absorption and utilisation generally and a within this portfolio blood glucose management (hypo- and hyperglycaemia control). Applications include glycogen storage diseases, type I and type II diabetes, liver disease, sport nutrition and applications for consumer health more generally. Other applications include disease states associated with carbohydrate digestion/ transport/ metabolism/ utilisation such as disorders specific to fructose, galactose, lactose, maltose and sucrose. 

What's new?

Portfolio of products under development.

Human clinical trials continue on the medical nutrition portfolio the Company is developing.  Trials on blood glucose control with new clinical nutrition products (crackers) are successful for healthy people and people with glycogen storage diseases and type I/type II diabetes.